Twist Bioscience Corp
For the period ended Sep 30, 2024. Filed Nov 18, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Nov 18, 2024
TWST$120.79+0.1%Stored close · as of Nov 6, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 2. Properties
Our principal facilities are described below:
| Principal Facilities | Approximate Square Footage | Lease Expiration | Use | Owned or Leased |
|---|---|---|---|---|
| Wilsonville, OR | 211,995 | 2044 | General & Administration and Manufacturing | Leased |
| South San Francisco, CA | 91,791 | 2028 | General & Administration, R&D and Manufacturing | Leased |
| Brisbane, CA | 24,786 | 2026 | Warehouse facility | Leased |
| Quincy, MA | 38,853 | 2032 | General & Administration, R&D and Manufacturing | Leased |
| Guangzhou, China | 9,956 | 2026 | General & Administration, Sales & Marketing and Supply Chain activities | Leased |
| Carlsbad, CA | 8,772 | 2026 | Sales & Marketing | Leased |
| Singapore | 1,353 | 2025 | Sales & Marketing | Leased |
The Company believes its existing facilities are in good operating condition and are suitable for the conduct of its business.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.